AGIBOT Laparoscopic Surgical Robot Achieves 100% Success in Multispecialty Trial

On August 14, 2024, AGIBOT Laparoscopic Surgical Robot completed its multicenter registration trial at Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine(hereinafter “Sir Run Run Shaw Hospital”), marking a milestone in China’s surgical robotics innovation. The trial concluded with two consecutive mediastinal tumor resections led by Prof. Zhu Ziyi’s thoracic team.

The clinical trial is led by Sir Run Run Shaw Hospital in collaboration with the First Affiliated Hospital of Zhengzhou University and the Chinese People’s Liberation Army (PLA) General Hospital (301 Hospital). Surgical disciplines participated in the trial include general surgery (hepatobiliary surgery, gastrointestinal surgery, and colorectal surgery), thoracic surgery, and gynecology surgery, covering a wide range of medium- to high-complexity procedures.

Under the guidance of Prof. Cai Xiujun, President of Sir Run Run Shaw Hospital, and collaborative efforts of experts including Prof. Liang Xiao, Prof. Wang Yong, Prof. He Zhengfu, Prof. Zhu Ziyi, and Prof. Chen Mingyu, the clinical trial progressed smoothly. Since the enrollment of the first patient in late June 2024, the AGIBOT Laparoscopic Surgical Robot has completed all trial surgeries in over ten operating days, while several operating days featured two or three back-to-back procedures.

The trial covered a variety of advanced surgical procedures, including partial hepatectomy, radical gastrectomy, radical colorectal cancer surgery, lobectomy/segmentectomy, mediastinal lesion resection, and esophageal cancer surgery. All procedures were successfully completed with a 100% success rate. Intraoperative parameters and postoperative outcomes indicated excellent surgical efficacy. The performance, effectiveness, and safety of the AGIBOT Laparoscopic Surgical Robot was unanimously endorsed by participating researchers.

Prof. Liang Xiao remarked: “The AGIBOT Laparoscopic Surgical Robot offers a groundbreaking surgical experience. Its precise control and high-definition visualization instill confidence in performing complex procedures. This robotic platform is not just a tool but a true surgical partner, enabling better outcomes for patients.”

Project Overview:

This clinical trial adopts a prospective, multi-centered, single-arm design with a target outcome approach. Led by Sir Run Run Shaw Hospital and involving collaboration with the First Affiliated Hospital of Zhengzhou University and PLA General Hospital(301 Hospital), the trial enlisted renowned surgeons from general surgery, thoracic surgery, and gynecology. The team conducted medium- to high-complexity laparoscopic surgeries, rigorously evaluating the efficacy and safety of the AGIBOT Laparoscopic Surgical Robot in multidisciplinary settings.

About the AGIBOT Laparoscopic Surgical Robot:

The AGIBOT Laparoscopic Surgical Robot is a cutting-edge system designed for minimally invasive procedures in urology surgery, gynecology surgery, general surgery, and thoracic surgery. It comprises a Surgeon Console with an integrated HD 3D monitor, a Patient Cart with four robotic arms featuring deployment guidance, a Vision Cart equipped with a 3D video fusion processor, and a suite of multi-degree-of-freedom surgical instruments and accessories.

The system offers precise, low-latency master-slave teleoperation, immersive high-definition 3D imaging, dexterous multi-degree-of-freedom instruments, and an intelligent real-time interactive interface. These innovative features aim to provide surgeons with an intuitive and efficient robotic-assisted surgical experience, achieving enhanced precision and synchronization between vision and operation.